Introduction
The ultimate end-point of a cancer-inducing exposure to a carcinogen is the appearance of a localized collection of cells (i) undergoing inappropriate proliferation, (ii) expanding locally and invading the surrounding tissue and (iii) releasing cells that generate in turn new collections of proliferating cells in distant sites. Most cancers are made up of heterogeneous cell populations with considerable diversity in cell structure, in chromosomal and genetic makeup and in biochemical properties as well as in states of differentiation. Although the cell type and biological behaviour do vary with different carcinogens, there is no known relationship between the nature and metabolism of the carcinogen and the nature of the ultimate cancer. Even though a minority of chemical carcinogens induce highly predictable types of neoplasms, e.g., vinyl chloride, 1,2-dimethylhydrazine, /3-naphthylamine, etc., modification of the conditions of exposure can change the spectrum of cancers induced. To cite but one example: with 1,2-dimethylhydrazine and some other carcinogens, acute exposure, when coupled with surgical partial hepatectomy, may induce a high incidence of liver cell cancer while in the absence of the surgical intervention, few or no such neoplasms are seen. To date, major correlations exist only between the cell or tissue distribution of the metabolizing and/or repair enzymes and the tissue site of cancer development but not with the nature of the cancer.
Thus, in most instances, cancer as an end-point and the types of cancer give little insight into how the chemical might be carcinogenic. Also, despite the intensity of human and material resources that have been focussed on cancer per se, the essential biochemical and genetic basis for the different major properties of cancers, such as autonomy of growth, invasion and metastasis, continue to elude the cancer researchers.
It is apparent, however, that the major behavioural properties of cancers are not acquired as a single step but rather seriatim or sequentially. This also pertains in most instances to the steps preceding the appearance of any of these characteristics. When and where studied, chemical carcinogens are related to cancer through a stepwise process that may often involve one half or more of the normal life span of that species. For example, in some rodents, a carcinogenic process lasting one or even two years is not uncommon. In humans, 20 years or longer is not unusual for many types of cancer. Also, once a collection of obviously malignant neoplastic cells does appear relatively late in the process, this is by no means a fixed end-point. Cancers in general continue to undergo further progression with selection toward increasing autonomy and invasion. Thus, in carcinogenesis, we are dealing with flexible systems of cellular changes in which cellular evolution to new © IRL Press Ltd., Oxford, England.
cell populations is a common feature. This again makes any delineation of a late discrete fine end-point difficult if not impossible.
The carcinogenic process
Given this state of the art, which unfortunately has not changed radically in several decades, increasing emphasis must be placed upon the pathogenesis of cancer, i.e., how does cancer develop, if we are ever to understand the mechanisms of how chemical carcinogens, both initiating and promoting, relate to cancer.
The past 15 years or so have seen a phenomenal development of knowledge concerning the metabolism of carcinogens, the nature of their activated forms, the interactions of such reactive derivatives with DNA and other cellular constituents and the repair systems for carcinogen-DNA adducts. Deeper insights have been generated into how these various components may be modulated by important endogenous and exogenous influences such as hormones, genetic background, nutrition and chemicals.
During this same period, some elementary principles of chemical carcinogenesis in the skin of mice and rabbits, especially the concept of initiation and promotion, have been extended to several other systems including the liver, urinary bladder, pancreas, colon and lung (1-3). Models are now available or are being developed that involve the ultimate appearance of cancer by two manipulations or operations, a relatively brief initiation and a more prolonged imposition of a promoting influence.
When viewed from the point of view of cell response and cell behaviour, i.e., from a biologial perspective, what is emerging from these various studies is a fairly clear-cut picture of the panorama -the dominance of certain patterns of tissue response and some of the key qestions that should be stressed.
Although we do not know all the various patterns of tissue and cellular responses that lead to cancer, one pattern stands out in many tissues with the vast majority of chemical carcinogens. In the skin, liver, colon (in some species), pancreas and several other sites, dicsrete new focal collections of cells, called nodules, papillomas or polyps, are virtually constant accompaniments of the carcinogenic process during the long precancerous or preneoplastic period. In the skin, in the liver and in the colon, these focal collections have been shown to be sites in which cancer can arise. Their possible role in the development of cancer in some models has been clearly established.
These focal collections arise from tissues that have been exposed to carcinogens under conditions of initiation. The nature of their progenitors in initiated tissues, so called 'initiated cells', their mode of development and their possible role in carcinogenesis are considered to be crucial items in my opinion and are one major topic for discussion. The second item of major importance in any discussion of carcinogenesis concerns the sequence of changes that these focal proliferations undergo as part of their possible role in the genesis of cancer. We consider these two topics to be central to the scientific analysis of the carcinogenic process in the present day perspective and their clarification to be essential to bridge the large gap between the chemistry and biochemistry of carcinogens and cancer development.
Genesis of nodules, papillomas and similar lesions
From the point of view of cancer development, the first major step is the genesis of altered cells during initiation. Although long suspected (4), it has only fairly recently been established that initiation in the liver (5 -8) and probably in other quiescent organs (9,10) requires a round of cell proliferation. This may well explain the observations made many times that metabolism with adduct formation in the liver with many carcinogens does not initiate carcinogenesis, unless the carcinogen induces cell death with regeneration (see 11)..
In the systems studied, and with the current assays, very few altered cells seem to be generated during initiation. This observation is consistent with the hypothesis that initiation is a rare event that could be due to some very uncommon change in the target cells, such as a mutation or some other type of genetic alteration.
What is the nature of the alteration in initiated cells that allows them to be expanded during promotion? The ability to be expanded, so called 'clonal expansion', is the phenotypic expression that dominates the phenomenon of promotion. Attempts to understand this fundamental question are continuously frustrated by an underlying consideration. Since any focal 'clonal' expansion involves a difference between the cells to be expanded and the surrounding cells and tissues, it becomes important to understand the biological nature of the expansion before any attempts at molecular mechanistic analysis are made. This may be best illustrated by an example. In any solid tissue, such as the liver, the presence of nodules is a reflection of a difference in how the nodule precursor cells respond as compared with their surrounding cells. If the 'initiated' cells have acquired a resistance to inhibition of cell proliferation by carcinogens or other compounds while the surrounding cells have not, if the liver is exposed to an appropriate inhibitor or cell proliferation and if a stimulus for cell proliferation is provided to the liver, the few 'initiated' resistant cells will respond 'normally' by proliferation while the majority will not. Thus, nodules can be rapidly generated under these conditions, as occurs in the resistant hepatocyte model of liver carcinogenesis (12) . This rapid appearance of hepatocyte nodules promotes cancer development. In this case, the mechanistic analysis of promotion must focus on at least two aspects of the system: (i) how specific or general is the resistance and what is its biochemical and genetic basis? and (ii) is the 'clonal expansion' sufficient for promotion to cancer or does the promoting environment impose some additional genetic or other change on the cell? If the acquired resistance is not a property that can be used for clonal expansion, its study as a basis for promotion would be quite irrelevant to carcinogenesis.
It is also probable that this mechanism of 'clonal' expansion, which may be called 'differential inhibition', is not universally applicable to the development of nodules and promotion in all models. For example, no differential inhibition is seen with orotic acid promotion, yet this is an excellent promoter for liver cancer (13) . Perhaps in this or other models, the 'initiated' hepatocytes show a difference in their primary response to a mitogenic stimulus, i.e., 'differential stimulation'. Clearly, such a biological basis for clonal expansion and promotion requires a different type of mechanistic analysis with an entirely different orientation.
This consideration also applies to the skin and all other organs or tissues in which focal collections of proliferating cells play a role in the carcinogenic process. How can one hope to understand a biochemical or molecular mechanism of a phenomenon, such as papilloma or nodule formation, without some understanding of the phenomenon under study? This seems appropriate for any biochemical, molecular or genetic analysis of a complex process, including those in disease. It raises the important question: can we hope to uncover the basic biochemical mechanism of any chemicallyinduced phenomenon, but especially one with the appearance of new cell populations, by only following the metabolism and fate of the chemical? Certainly, from today's perspective, a heavier emphasis on the reverse approach, the delineation of the biological phenomenon and then its mechanistic analysis, would seem to be equally or perhaps more appropriate.
In respect to the genesis of nodules, papillomas and analogous lesions, do different promoting environments select different types of altered cells in an initiated tissue or is there only one type of 'initiated' cell? Although fundamental, this question obviously must await a better understanding of how different promoting environments in each tissue select carcinogen-altered cells for expansion. Since initiated cells, after expansion, show a whole pattern of phenotypic changes and not just one or two, it is conceivable that different promoting environments use different 'handles' in the same initiated cell for their selections.
A common pattern of gene expression
One of the more striking aspects of chemical carcinogenesis are the observations that the nodules, papillomas and polyps generated in quite different models show an unusual degree of similarity in cellular composition and organization and in other properties. This has been most intensively studied in the liver.
The hepatocyte nodules, generated in five different models (intermittent chronic exposure, resistant hepatocyte, chronic enzyme induction (phenobarbital), choline deficient diet, orotic acid (see 14, 15) ) are in general similar not only in respect to architectural arrangement of hepatocytes, blood supply and negative and positive histochemical markers (14) but also in their metabolic biochemical pattern (16 -23) . The pattern can be related to an increased resistance to many xenobiotics. The decreased metabolism of carcinogens by the microsome mixed function oxygenase system (decrease in cytochromes P450 and in several oxygenases), the increased conjugation of reactive metabolites with glutathione and glucuronic acid (increase in glutathione, glutathione-Stransferase and a UDP-glucuronyl transferase), the decrease in sulfotransferase, the accelerated hydration of epoxides by epoxide hydrolase, and the accelerated reduction of quinones by DT-diaphorase (quinone reductase) present an unusually special phenotypic program consistent with a general increase in resistance to the cytotoxic effects of some foreign materials. Studies in whole animals have shown that the biochemical pattern is reflected in altered pharmacodynamics of at least one carcinogen, 2-acetylaminofluorene. Decreased ac-tivation and more efficient conjugation and excretion in the urine are among the obvious differences between control animals and animals with nodules in their liver (24) . Also, with two carcinogens and two hepatotoxic chemicals, decreased activation, decreased interaction with macromolecules and decreased acute cytotoxicity are seen in nodules (25) . Another interesting feature is the presence of a common pattern of change in cytosolic proteins, the most obvious change being a considerable increase in a 21 kD protein in nodules generated in each of the five models (21) .
This commonality in gene expression appears to be constitutive, since it is quite independent of the continuing exposure to the carcinogen or promoting environment in at least some instances. For example, it is seen in nodules 15 months after transfer to the spleens of syngeneic control rats. These transfers often evolve into unequivocal hepatocellular carcinoma (26) .
It should be pointed out that the biochemical or metabolic patterns have not been explored in nodules generated by carcinogens that are not mutagenic or only mildly so or by the feeding of choline deficient diets without added carcinogens (27, 28) . The best examples are with the hypolipidemic agents that induce nodules and hepatocellular carcinoma but are not positive in many short term tests (29, 30) . Whether these nodules will be similar to those seen in the other five models is an interesting question.
Nodule or papilloma to cancer sequence Options for nodules and papillomas
During initiation, tens (in the skin) or hundreds or thousands (in the liver) of altered cells are often induced and each of these can be expanded to form papillomas or nodules by an appropriate promoting environment. Yet, in most models, only one cancer or perhaps a few may be seen even under optimal conditions. This is also the experience in the colon in some humans who have an hereditary disease called multiple polyposis. Only very few of thousands of polyps act as precursors for cancer development.
In at least the skin and the liver, the crucial turning point in the carcinogenic sequence to cancer occurs at the nodule stage. In both of these sites and probably also at other sites such as the colon, the majority of the papillomas or nodules in some models often 'disappear' as such and only a small minority persist. However, there are indications that the percentages of nodules or papillomas that remodel may vary with the model. For example, in the skin, more papillomas regress when the promoter is an active phorbol ester than when it is a carcinogen (31).
The persistent nodules or papillomas in turn are the sites for further focal change in a few cells to generate new cell populations. In the skin, ultimately, cancer may appear in such papillomas by a process as yet undescribed. In the liver, the few persistent nodules are the sites for new focal cell populations ('nodules in nodules') (15) . This new population may expand and in turn may become the site of a further focal cellular change. How many such steps are involved in cancer development is unknown. However, in a few instances, metastasizing cancer can be seen to arise in such a manner.
A critical question for cancer development then becomes the basic nature of the 'disappearing' process of the majority of nodules or papillomas and the reasons for persistence. The 'disappearance of papillomas' in the skin has not been studied very much. In the liver, recent work has clearly established that the nodules 'disappear' by undergoing remodeling to normal-appearing liver by a process of redifferentiation (32) . For unknown reasons, the few persistent nodules either fail to show the redifferentiation or do it very slowly. Presumably, the new focal cell population arises in such nodules before redifferentiation can take place. Unlike the population of early nodules, the persistent ones grow well in the spleen and may evolve into cancer (26, 33) .
An important question that remains unexplored to date is whether the two major options elected by nodules or papillomas are determined by the exposure to the carcinogen during initiation or by the promoting environment or are stochastic and based only on chance and probability.
It must be emphasized that once the persistent nodule is generated, no further external manipulations or operations are needed for cancer development. In other words, the longest period in the carcinogenic process, the nodule-papilloma to cancer sequence, is 'self generating'. This period consists of steps, probably several, yet somehow it can progress without the need for any other external manipulation by the investigator. Is this compatible with a popular speculation on the 'multi-hit' formulation? In two systems, the skin and the liver, some further progression beyond the papilloma or the nodule has been observed with the further exposure to carcinogens (34, 35) . Is this truly a reflection of what is happening during the long 'self generating' period in chemical carcinogenesis?
Subsequent steps
As already pointed out, malignant neoplasia is itself a stepwise process with at least three discrete phenomena. Judging from our current knowledge about the liver models, there would appear to be a further stepwise sequence between the persistent nodule and the first appearance of a probable malignant neoplastic population.
Overall, this period in the carcinogenic process appears to be a long one. In at least some models, the overall rate limiting step or steps reside somewhere in this sequence. Its nature remains to be studied. However, it is already evident that modulation of a major magnitude can exist in this period. For example, in one model of liver carcinogenesis, the administration of progesterone can significantly increase the growth of a few nodules while (3-estradiol accelerates remodeling (36) . It is anticipated that diet, drugs and hormones might have a major impact upon the carcinogenic process through exercising some influence on the persistent nodule-papilloma to cancer sequence.
This raises an important general feature. In the skin system, there is evidence that the genesis of papillomas may be divisible into at least two steps and that each can be influenced by different agents (37, 38) . Clearly, a goal of research in carcinogenesis is to divide the process into as many steps as are real and then to begin to place them into a meaningful perspective so as to understand their role in the development of cancer.
Some general considerations
One of the most interesting questions concerning the mechanisms in chemical carcinogenesis is: what are the contributions of a carcinogen to cancer development? As initiators, most carcinogens clearly induce a few altered cells in the target tissue and these few cells can act as sites of cellular expansion to form papillomas, nodules, polyps and similar focal collections. Is this the sum total of the contributions of the initiating component of a carcinogen?
As promoters, carcinogens also induce the expansion of the few cells altered during initiation. Does the carcinogen add any other information to the expanding cell population or only a means for 'clonal' expansion? Under these conditions, is the 'self generating' nature of the subsequent progression to cancer merely an illusion? Perhaps the promoting or initiating action of the carcinogen also induces built in changes that require many cell cycles or merely time to express themselves? Is this feasible, given the number of steps involved in the process until the stage of metastasizing cancer is reached?
In vitro versus in vivo
The emphasis in this presentation has been on in vivo. Since an increasing number of studies are being done on in vitro systems, what is their relevance to what happens in the intact animals or in humans? The in vitro transformation with chemicals occurs in a stepwise fashion (39) . Also, promoters as well as initiators seem to have analogous effects in vitro and in vivo. However, the identification of new cells and their nature remains to be delineated in a manner analogous to what is being developed in vivo. Presumably, it may become possible ultimately to superimpose at least some of the in vitro steps on those in vivo, since detailed mechanistic studies will require the availability of appropriate in vitro models for the different steps.
Oncogenes and carcinogenesis
A topic of great current interest is the step or steps at which some of the oncogenes fit into the biological perspective of carcinogenesis (40) . It is too early to make any judgements, even very tentative ones. Since much of the recent work on human cancers has involved very advanced cancer or even cell cultures from such cancers and since only a maximum of 15% of any type of cancer has been positive in transfection assays, it is impossible to place 'the oncogene' into a specific site in the stepwise carcinogenic process today. However, three recent reports (41) (42) (43) suggest that some oncogenes may work in concert with each other or with viruses or chemicals in human or rat cells in culture in a stepwise transformation in vitro. The effects of the oncogenes were manifested after the effects of the chemicals or viruses in a process that involved at least two or three steps. Clearly, a major challenge is now offered by the recent work on oncogenes. If they play a role in the carcinogenic process and are not an expression of advanced progression in the post-cancer sequence, at what step or stage do they participate and what is/are their mechanism(s) of action?
Carcinogenesis as a physiological process
The common properties of the hepatic nodules, the ability of nodules to undergo the very complex process of redifferentiation during remodeling and the nature of the changes seen in the preneoplastic segment of carcinogenesis suggest that at least some of the earlier steps are physiological, as opposed to aberrant or 'pathological' and that they might represent a form of adaptation to xenobiotics with survival value (3) .
Based upon these and other considerations, it may be appropriate to begin to formulate new specific hypotheses for initiation. The current experience in the biochemical-biological synthesis in hepatocarcinogenesis suggests the possible role of a major regulatory gene for the constellation of biochemical changes seen in expanded initiated cells. This major regulatory gene would control in a coordinate way patterns of gene expression relating to the handling of many xenobiotics by the liver cells.
Judging by the experience to date in carcinogenesis in the rat liver, it might be profitable to begin to view the process of cancer development with chemicals in a somewhat broader biological context than heretofore and to further explore the close interplay between chemistry, biochemistry and biology.
